Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts

Background: Combining a fraction of exhaled nitric oxide (FeNO) and blood eosinophil count (B-EOS) may be a useful strategy for administration of biologics such as anti-IgE or anti-IL-5 to patients with type 2 inflammatory-predominant severe asthma and is important to be elucidated considering the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshino, Yuki, Soma, Tomoyuki, Uchida, Yoshitaka, Shiko, Yuki, Nakagome, Kazuyuki, Nagata, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065285/
https://www.ncbi.nlm.nih.gov/pubmed/35517829
http://dx.doi.org/10.3389/fphar.2022.836635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065285/
https://www.ncbi.nlm.nih.gov/pubmed/35517829
http://dx.doi.org/10.3389/fphar.2022.836635

Ejemplares similares